IN2014CN02972A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN02972A IN2014CN02972A IN2972CHN2014A IN2014CN02972A IN 2014CN02972 A IN2014CN02972 A IN 2014CN02972A IN 2972CHN2014 A IN2972CHN2014 A IN 2972CHN2014A IN 2014CN02972 A IN2014CN02972 A IN 2014CN02972A
- Authority
- IN
- India
- Prior art keywords
- corneal
- riboflavin
- keratoconus
- permeation
- guarantee
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000560A ITRM20110560A1 (it) | 2011-10-25 | 2011-10-25 | Migliorata composizione di cross-linking per il trattamento del cheratocono mediante iontoforesi |
| PCT/IT2012/000324 WO2013061350A1 (en) | 2011-10-25 | 2012-10-24 | Improved cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN02972A true IN2014CN02972A (ru) | 2015-07-03 |
Family
ID=45315962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2972CHN2014 IN2014CN02972A (ru) | 2011-10-25 | 2012-10-24 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9439908B2 (ru) |
| EP (1) | EP2770979B1 (ru) |
| JP (1) | JP5913606B2 (ru) |
| KR (1) | KR101837238B1 (ru) |
| AU (1) | AU2012327916B2 (ru) |
| BR (1) | BR112014009761B8 (ru) |
| CA (1) | CA2851331C (ru) |
| EA (1) | EA026703B1 (ru) |
| ES (1) | ES2546263T3 (ru) |
| IL (1) | IL232194A (ru) |
| IN (1) | IN2014CN02972A (ru) |
| IT (1) | ITRM20110560A1 (ru) |
| MX (1) | MX342930B (ru) |
| PT (1) | PT2770979E (ru) |
| RS (1) | RS54139B1 (ru) |
| WO (1) | WO2013061350A1 (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9622911B2 (en) | 2010-09-30 | 2017-04-18 | Cxl Ophthalmics, Llc | Ophthalmic treatment device, system, and method of use |
| EP2663281B1 (en) | 2011-01-12 | 2016-08-10 | Sooft Italia Spa | Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions |
| WO2013149075A1 (en) | 2012-03-29 | 2013-10-03 | Cxl Ophthalmics, Llc | Compositions and methods for treating or preventing diseases associated with oxidative stress |
| WO2013148896A1 (en) | 2012-03-29 | 2013-10-03 | Cxl Ophthalmics, Llc | Ocular treatment solutions, delivery devices and delivery augmentation methods |
| US9931199B2 (en) * | 2014-05-05 | 2018-04-03 | Roberto Gustavo ALBERTAZZI | Methods and apparatus for treating keratoconus |
| JP6933377B2 (ja) | 2015-07-21 | 2021-09-08 | アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． | 光増感剤を用いた眼の処置用システム及び方法 |
| EP3442481B1 (en) | 2016-04-13 | 2023-06-28 | Avedro, Inc. | Systems for delivering drugs to an eye |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030023228A1 (en) * | 2001-07-20 | 2003-01-30 | Parkinson Thomas M. | Ocular iontophoretic device and method for using the same |
| ITRM20070356A1 (it) * | 2007-06-26 | 2008-12-27 | Sooft Italia Srl | Soluzione oculare sterile monouso e suo procedimento di produzione per il cross linking corneale del cheratocono |
| IT1393402B1 (it) * | 2008-08-28 | 2012-04-20 | Sooft Italia Spa | Uso di enhancer eventualmente con riboflavina, nonche' relative composizioni oftalmiche per cross-linking corneale del cheratocono o di altre patologie ectasiche corneali |
| EP2289937A1 (en) | 2009-08-24 | 2011-03-02 | Wilfried Stücker | Production of monoclonal antibodies in vitro |
| WO2011130356A2 (en) * | 2010-04-13 | 2011-10-20 | Avedro, Inc. | Systems and methods for activating cross-linking in an eye |
-
2011
- 2011-10-25 IT IT000560A patent/ITRM20110560A1/it unknown
-
2012
- 2012-10-24 US US14/353,872 patent/US9439908B2/en active Active
- 2012-10-24 WO PCT/IT2012/000324 patent/WO2013061350A1/en active Application Filing
- 2012-10-24 IN IN2972CHN2014 patent/IN2014CN02972A/en unknown
- 2012-10-24 CA CA2851331A patent/CA2851331C/en active Active
- 2012-10-24 EA EA201490845A patent/EA026703B1/ru not_active IP Right Cessation
- 2012-10-24 ES ES12813534.0T patent/ES2546263T3/es active Active
- 2012-10-24 JP JP2014537816A patent/JP5913606B2/ja not_active Expired - Fee Related
- 2012-10-24 RS RS20150504A patent/RS54139B1/en unknown
- 2012-10-24 KR KR1020147013678A patent/KR101837238B1/ko active IP Right Grant
- 2012-10-24 BR BR112014009761A patent/BR112014009761B8/pt active IP Right Grant
- 2012-10-24 AU AU2012327916A patent/AU2012327916B2/en active Active
- 2012-10-24 PT PT128135340T patent/PT2770979E/pt unknown
- 2012-10-24 MX MX2014004297A patent/MX342930B/es active IP Right Grant
- 2012-10-24 EP EP12813534.0A patent/EP2770979B1/en active Active
-
2014
- 2014-04-22 IL IL232194A patent/IL232194A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| IL232194A0 (en) | 2014-06-30 |
| AU2012327916B2 (en) | 2016-04-21 |
| IL232194A (en) | 2016-09-29 |
| AU2012327916A1 (en) | 2014-05-22 |
| KR101837238B1 (ko) | 2018-03-09 |
| US20140303173A1 (en) | 2014-10-09 |
| CA2851331A1 (en) | 2013-05-02 |
| PT2770979E (pt) | 2015-10-07 |
| ES2546263T3 (es) | 2015-09-22 |
| WO2013061350A1 (en) | 2013-05-02 |
| CA2851331C (en) | 2019-11-12 |
| US9439908B2 (en) | 2016-09-13 |
| MX342930B (es) | 2016-10-19 |
| EP2770979A1 (en) | 2014-09-03 |
| BR112014009761A2 (pt) | 2017-04-25 |
| EA201490845A1 (ru) | 2014-07-30 |
| MX2014004297A (es) | 2014-07-24 |
| CN104023706A (zh) | 2014-09-03 |
| EP2770979B1 (en) | 2015-07-08 |
| ITRM20110560A1 (it) | 2013-04-26 |
| BR112014009761B1 (pt) | 2022-05-24 |
| EA026703B1 (ru) | 2017-05-31 |
| JP2014530904A (ja) | 2014-11-20 |
| BR112014009761B8 (pt) | 2022-09-06 |
| JP5913606B2 (ja) | 2016-04-27 |
| RS54139B1 (en) | 2015-12-31 |
| KR20140080553A (ko) | 2014-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CN02972A (ru) | ||
| IL227412A (en) | Administration of cross-materials to corne by iontophoresis for the treatment of keratoconus and ophthalmic preparations for this purpose | |
| MX2019000586A (es) | Virus adenoasociados (aav) sflt-1 para usarse en el tratamiento de degeneración macular relacionada con la edad (amd). | |
| NZ630805A (en) | Pharmaceutical combinations comprising a thionucleotide analog | |
| PH12015501067A1 (en) | Pyrrolopyrimidine compounds as kinase inhibitors | |
| IN2014DN09594A (ru) | ||
| TN2014000356A1 (en) | Heterocyclyl compounds as mek inhibitors | |
| EA028156B9 (ru) | Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов | |
| MY171920A (en) | Prevention and treatment of ocular conditions | |
| EA201590053A1 (ru) | Модуляторы пути системы комплемента и их применение | |
| GEP201706786B (en) | Methods and drug products for treating alzheimer's disease | |
| MX361858B (es) | Formulación oftálmica de lípido polioxilo o de ácido graso polioxilo y tratamiento de padecimientos oculares. | |
| MX2014005209A (es) | Un medicamento para tratar la enfermedad del ojo anterior que comprende rebamipida y un agente de retencion de lagrimas. | |
| EP2490700A4 (en) | EXTERNAL SKIN CARE COMPOSITION COMPRISING SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND USE THEREOF | |
| PH12015500653B1 (en) | Combination drug comprising gemigliptin and metformin, and method for the preparation thereof | |
| NZ766141A (en) | Isoxazoline parasiticide formulations and methods for treating blepharitis | |
| WO2014071168A3 (en) | Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients | |
| BR112015004469A2 (pt) | sirna e seu uso em métodos e composições para o tratamento e/ou prevenção de condições oculares | |
| IN2014DN09437A (ru) | ||
| MX2016005614A (es) | Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos. | |
| MX2013008635A (es) | Mejoras de y relacionadas con composiciones. | |
| WO2016030899A8 (en) | Methods of treating amyotrophic lateral scleroses | |
| PH12019501785A1 (en) | Intranasal composition comprising betahistine | |
| MX2015009414A (es) | Agentes analgesicos oculares topicos. | |
| MX362485B (es) | Nuevos inhibidores de rock. |